Clinical trials in neuro-oncology are becoming increasingly complex. Patients may undergo imaging over months or even years, with every new...
For years, imaging in neuro-oncology clinical trials has relied on established response assessment criteria and expert radiologist interpretation....
QMENTA vs. Quibim: A strategic comparison of two medical imaging AI platforms — reproducible CNS trial endpoints vs. hospital radiology diagnostics.
Discover what's new in QMENTA Platform 4.2, including preserved manual workflows, improved DICOM performance, modern authentication, audit logging,...
Compare QMENTA vs icometrix neuroimaging platforms: clinical trial infrastructure vs point-of-care diagnostics. Choose the right solution for MS...
Multi-site neuroimaging trials face protocol drift, QC bottlenecks, and audit gaps. A 2026 look at operational realities and what actually impacts...
QMENTA vs. Flywheel.io: Compare FDA-cleared CNS clinical AI vs. enterprise R&D infrastructure. See which medical imaging platform fits your trial.
QMENTA vs Medidata Rave Imaging: compare AI biomarkers, central review, imaging EDC, and which platform fits your clinical trial.
This post reviews QMENTA's 2025 progress in clinical imaging infrastructure, including enterprise security compliance, regulatory validation with...